title: A worrying thought--could there be a connection between encapsulating peritoneal sclerosis, tamoxifen and calciphylaxis?
authors.affiliation: Department of Nephrology, Hasharon Hospital-Rabin Medical Center, Petach Tikva 49372, Israel.
authors.forename: Asher
authors.initials: A
authors.lastname: Korzets
authors.forename: Yaacov
authors.initials: Y
authors.lastname: Ori
authors.forename: Dina
authors.initials: D
authors.lastname: Zevin
authors.forename: Avry
authors.initials: A
authors.lastname: Chagnac
authors.forename: Michal
authors.initials: M
authors.lastname: Herman
authors.forename: Benaya
authors.initials: B
authors.lastname: Rozen-Zvi
authors.forename: Uzi
authors.initials: U
authors.lastname: Gafter
mesh_terms: D002115:Calciphylaxis / Q000175:diagnosis / Q000209:etiology; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010532:Peritoneal Diseases / Q000188:drug therapy / Q000209:etiology*; D010537:Peritoneum / Q000187:drug effects / Q000473:pathology*; D006435:Renal Dialysis / Q000009:adverse effects*; D012598:Sclerosis; D013629:Tamoxifen / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D013629:Tamoxifen